With the closing of its Series A and a €12 million extension round, Munich-based deepc, the AI radiology startup, has reached a total funding of €27.6 million.
Along with participation from new investors KHP Ventures and SwissHealth Ventures as well as returning partner Winning Mindset Ventures, the funding was co-led by Sofinnova Partners and Bertelsmann Investments.
deepc will use the money to develop and market its leading operating system and accelerate the company’s growth and global expansion. deepc expansion in the US, its continued growth in the UK, and its concentration on important European markets are among its top growth targets.
Leading institutions now use deepc’s platform, including the National Health Service (NHS) in England, the Vivantes Hospital Group and LMU University Hospital in Germany, CHU Brugmann (Brugmann University Hospital) in Belgium, and Solothurn Hospital in Switzerland.
Dr. Franz Pfister, CEO and co-founder of the deepc:
“At deepc, we believe that the potential for AI in healthcare will only be realized if we can bridge the gap between cutting-edge AI and clinical practice, With the help of our platform, businesses can quickly and easily implement the most cutting-edge AI technologies, leading to quicker and more precise diagnoses and better patient outcomes overall. Together with our current investors, Sofinnova Partners, Bertelsmann Investments, and Winning Mindset Ventures, we are delighted to welcome SwissHealth Ventures and KHP Ventures. When combined, they offer deepc enormous strategic value and will be a valuable resource as we expand globally and make more platform investments.”
Related Content: BioTech startup MultiplAI Health Snaps $2.7M
deepc ensures that all patients receive accurate and secure diagnostics. The company has a proven track record of assisting radiology AI suppliers in deploying their technologies in clinical settings by providing a single integration solution.
Clinicians can now access the rapid advancements in radiology AI through deepcOS®, which gives them access to regulatory-approved AI solutions for over 60 clinical indications. This eliminates any technological, operational, or financial complications and lets healthcare providers take advantage of these advancements. deepc is also contributing to the acceleration of the creation of new AI solutions by providing low-barrier access to its extensive client base and distribution network, which spans more than 30 countries.
Simon Turner, a partner at Sofinnova Partners, said:
“The influx of capital into AI is highlighting the importance of enabling technologies that drive adoption in healthcare. The Sofinnova Digital Medicine strategy is centered on these enabling technologies, an area that few people now control. We saw early on that deepc might completely transform the application of AI in healthcare. The support of our new investors, who offer a wealth of experience to drive the company’s growth further, confirms this commitment today.”
